KEY PRODUCTS
Veranova: A CDMO that manages complexity with confidence.
01 1Veranova
01 1BUPRENORPHINE
01 1U.S.A
01 1Active
01 1Complete
Veranova: A CDMO that manages complexity with confidence.
GDUFA
DMF Review : Complete
Rev. Date : 2013-11-08
Pay. Date : 2012-12-12
DMF Number : 26448
Submission : 2012-09-17
Status : Active
Type : II
20
Macfarlan Smith Ltd A Johnson Matthey Co, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Veranova: A CDMO that manages complexity with confidence.
One of their notable products is BUPRENORPHINE, with a corresponding US DMF Number 26448.
Remarkably, this DMF maintains an Active status since its submission on September 17, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 08, 2013, and payment made on December 12, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
